PBH Insider Trading

Insider Ownership Percentage: 1.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,338,320.40

Prestige Consumer Healthcare Insider Trading History Chart

This chart shows the insider buying and selling history at Prestige Consumer Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M$0$2MTotal Insider BuyingTotal Insider Selling

Prestige Consumer Healthcare Share Price & Price History

Current Price: $84.23
Price Change: Price Increase of +2 (2.43%)
As of 05/2/2025 04:59 PM ET

This chart shows the closing price history over time for PBH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$84.23Closing price on 05/03/25:

Prestige Consumer Healthcare Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Prestige Consumer Healthcare (NYSE:PBH)

99.95% of Prestige Consumer Healthcare stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PBH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$34Mbought$61MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400M-$200M$0$200M$400MTotal InflowsTotal Outflows
Prestige Consumer Healthcare logo
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More on Prestige Consumer Healthcare

Today's Range

Now: $84.23
Low: $82.83
High: $84.90

50 Day Range

MA: $83.27
Low: $78.62
High: $89.10

52 Week Range

Now: $84.23
Low: $62.35
High: $90.04

Volume

340,824 shs

Average Volume

290,977 shs

Market Capitalization

$4.17 billion

P/E Ratio

19.73

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Prestige Consumer Healthcare?

Prestige Consumer Healthcare's top insider shareholders include:
  1. Ronald M Lombardi (CEO)
  2. William P'pool (Insider)
  3. Mary Beth Fritz (SVP)
  4. Adel Mekhail (EVP)
Learn More about top insider investors at Prestige Consumer Healthcare.

Who are the major institutional investors of Prestige Consumer Healthcare?

Prestige Consumer Healthcare's top institutional investors include:
  1. Allspring Global Investments Holdings LLC — 3.26%
  2. Victory Capital Management Inc. — 2.31%
  3. Congress Asset Management Co. — 2.00%
  4. Boston Trust Walden Corp — 1.65%
  5. Massachusetts Financial Services Co. MA — 1.34%
  6. Rice Hall James & Associates LLC — 1.10%
Learn More about top institutional investors of Prestige Consumer Healthcare stock.

Which major investors are selling Prestige Consumer Healthcare stock?

During the last quarter, PBH stock was sold by these institutional investors:
  1. Victory Capital Management Inc.
  2. Massachusetts Financial Services Co. MA
  3. Assenagon Asset Management S.A.
  4. Wedge Capital Management L L P NC
  5. Leeward Investments LLC MA
  6. Boston Trust Walden Corp
  7. Bank of New York Mellon Corp
  8. Rhumbline Advisers
In the previous year, company insiders that have sold Prestige Consumer Healthcare company stock include:
  1. Ronald M Lombardi (CEO)
  2. William P'pool (Insider)
  3. Mary Beth Fritz (SVP)
  4. Adel Mekhail (EVP)
Learn More investors selling Prestige Consumer Healthcare stock.

Which major investors are buying Prestige Consumer Healthcare stock?

During the last quarter, PBH stock was bought by institutional investors including:
  1. GAMMA Investing LLC
  2. Congress Asset Management Co.
  3. Bessemer Group Inc.
  4. Advisor Resource Council
  5. EULAV Asset Management
  6. Envestnet Asset Management Inc.
  7. Principal Financial Group Inc.
  8. NorthCrest Asset Manangement LLC